Titles: S.3187 — 112th Congress (2011-2012)All Information (Except Text)

Short Titles

Short Titles as Enacted

Food and Drug Administration Safety and Innovation Act

Short Titles as Enacted for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012
  • Synthetic Drug Abuse Prevention Act of 2012

Short Titles - House of Representatives

Short Titles as Passed House

Food and Drug Administration Safety and Innovation Act

Short Titles as Passed House for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012
  • Synthetic Drug Abuse Prevention Act of 2012

Short Titles - Senate

Short Titles as Passed Senate

Food and Drug Administration Safety and Innovation Act

Short Titles as Passed Senate for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012
  • Synthetic Drug Abuse Prevention Act of 2012

Short Titles as Introduced

Food and Drug Administration Safety and Innovation Act

Short Titles as Introduced for portions of this bill
  • Biosimilar User Fee Act of 2012
  • Generic Drug User Fee Amendments of 2012
  • Medical Device User Fee Amendments of 2012
  • Prescription Drug User Fee Amendments of 2012

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.